Amantadine hydrochloride
- Product NDC
- 69844-026
- 11-digit product format
- 698440026
- Labeler code
- 69844
- Product ID
- 69844-026_c8aebadf-606e-4d0a-85b9-2384c98b25b7
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Amantadine hydrochloride
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- Graviti Pharmaceuticals Private Limited
- Application
- ANDA207570
- Marketing category
- ANDA
- Marketing start
- 2016-09-30
- Marketing end
- 0000-00-00
- Substance
- AMANTADINE HYDROCHLORIDE
- Active strength
- 100 mg/1
- Pharmacologic classes
- Influenza A M2 Protein Inhibitor [EPC],M2 Protein Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2020-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 69844-026-03 | Amantadine hydrochloride | 100 in 1 BOTTLE | CAPSULE | 100 | | 1 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 69844-026 | AMANTADINE HYDROCHLORIDE CAPSULE [GRAVITI PHARMACEUTICALS PRIVATE LIMITED] | 1 | Legacy NDC, 1 package rows | 20190208_72139373-8de5-4acb-be0f-07036fa41eeb.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Status |
|---|
| 69844-026-03 | 69844002603 | 100 in 1 BOTTLE | Historical |